NICHOLAS SISOFO: Open Payments
NPI 1700544103 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,790 in 101 payments from 17 companies in 2025. Trend: 2023 $2,913 · 2024 $1,285 · 2025 $2,790
Food & beverage: $2,790
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $499 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $338 |
| Supernus Pharmaceuticals, Inc. | 9 | $321 |
| Otsuka America Pharmaceutical, Inc. | 8 | $260 |
| Axsome Therapeutics, Inc. | 11 | $247 |
| E.R. Squibb & Sons, L.L.C. | 4 | $182 |
| ABBVIE INC. | 12 | $180 |
| Alkermes, Inc. | 4 | $169 |
| Collegium Pharmaceutical, Inc. | 7 | $142 |
| Almatica Pharma LLC | 10 | $135 |
Products named: HETLIOZ, CAPLYTA, Qelbree, REXULTI, Auvelity, COBENFY, VRAYLAR, Jornay PM.
Industry payments across SC — which companies pay providers there.
